Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 3
2007 3
2008 1
2009 2
2010 1
2011 4
2012 7
2013 7
2014 5
2015 11
2016 5
2017 7
2018 8
2019 12
2020 9
2021 19
2022 10
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Endothelium structure and function in kidney health and disease.
Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT. Jourde-Chiche N, et al. Among authors: roumenina lt. Nat Rev Nephrol. 2019 Feb;15(2):87-108. doi: 10.1038/s41581-018-0098-z. Nat Rev Nephrol. 2019. PMID: 30607032 Review.
C1q+ macrophages: passengers or drivers of cancer progression.
Revel M, Sautès-Fridman C, Fridman WH, Roumenina LT. Revel M, et al. Among authors: roumenina lt. Trends Cancer. 2022 Jul;8(7):517-526. doi: 10.1016/j.trecan.2022.02.006. Epub 2022 Mar 12. Trends Cancer. 2022. PMID: 35288093 Review.
C3-dependent effector functions of complement.
Zarantonello A, Revel M, Grunenwald A, Roumenina LT. Zarantonello A, et al. Among authors: roumenina lt. Immunol Rev. 2023 Jan;313(1):120-138. doi: 10.1111/imr.13147. Epub 2022 Oct 22. Immunol Rev. 2023. PMID: 36271889 Free PMC article. Review.
Context-dependent roles of complement in cancer.
Roumenina LT, Daugan MV, Petitprez F, Sautès-Fridman C, Fridman WH. Roumenina LT, et al. Nat Rev Cancer. 2019 Dec;19(12):698-715. doi: 10.1038/s41568-019-0210-0. Epub 2019 Oct 30. Nat Rev Cancer. 2019. PMID: 31666715 Review.
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ; Conference Participants. Goodship TH, et al. Among authors: roumenina lt. Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16. Kidney Int. 2017. PMID: 27989322 Free article.
Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis.
Boudhabhay I, Poillerat V, Grunenwald A, Torset C, Leon J, Daugan MV, Lucibello F, El Karoui K, Ydee A, Chauvet S, Girardie P, Sacks S, Farrar CA, Garred P, Berthaud R, Le Quintrec M, Rabant M, de Lonlay P, Rambaud C, Gnemmi V, Fremeaux-Bacchi V, Frimat M, Roumenina LT. Boudhabhay I, et al. Among authors: roumenina lt. Kidney Int. 2021 Mar;99(3):581-597. doi: 10.1016/j.kint.2020.09.033. Epub 2020 Nov 1. Kidney Int. 2021. PMID: 33137339 Free article.
COMPLEMENTing immunotherapy.
Roumenina LT, Cremer I. Roumenina LT, et al. Nat Cancer. 2022 Oct;3(10):1144-1146. doi: 10.1038/s43018-022-00442-6. Nat Cancer. 2022. PMID: 36271171 No abstract available.
Complement System Part II: Role in Immunity.
Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Merle NS, et al. Among authors: roumenina lt. Front Immunol. 2015 May 26;6:257. doi: 10.3389/fimmu.2015.00257. eCollection 2015. Front Immunol. 2015. PMID: 26074922 Free PMC article. Review.
Heme: driver of erythrocyte elimination.
Dimitrov JD, Roumenina LT. Dimitrov JD, et al. Among authors: roumenina lt. Blood. 2021 Sep 30;138(13):1092-1094. doi: 10.1182/blood.2021012875. Blood. 2021. PMID: 34591096 Free article. No abstract available.
109 results